Raphael Schiffmann, MD
Potential Financial Conflicts of Interest: The author has led and is currently leading clinical research studies on another enzyme replacement treatment for Fabry disease in collaboration with Shire Human Genetic Therapies (previously Transkaryotic Therapies Inc.). As an employee of the National Institutes of Health, Dr. Schiffmann does not receive compensation from Shire Human Genetic Therapies. The company has paid his travel expenses to meetings related to the research collaboration.
Requests for Single Reprints: Raphael Schiffmann, MD, National Institutes of Health, Building 10, Room 3D03, 9000 Rockville Pike, Bethesda, MD 20892-1260; e-mail, RS4e@nih.gov.
Schiffmann R. Enzyme Replacement in Fabry Disease: The Essence Is in the Kidney. Ann Intern Med. 2007;146:142–144. doi: https://doi.org/10.7326/0003-4819-146-2-200701160-00147
Download citation file:
Published: Ann Intern Med. 2007;146(2):142-144.
Encephalopathy, Nephrology, Neurology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use